CLEAN ENERGY TECHNOLOGIES, INC. (CETY)
Clean Energy Technologies Receives Notice of Deficiency from Nasdaq
Clean Energy Technologies Receives Notice of Deficiency from Nasdaq
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice
$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors
Sable Offshore Corp. to Host Conference Call on June 1, 2026
Celularity Receives Nasdaq Notice Regarding Form 10-Q
BRW Announces Notification of Sources of Distributions
Celularity Receives Nasdaq Notice Regarding Form 10-Q